Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes Study

PURPOSE: Financial toxicity is highly prevalent in oncology. Early identification of at-risk patients is essential because financial toxicity is associated with inferior outcomes. Validated general oncology screening tools are cumbersome and not specific to challenges related to radiation therapy, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Rahul N., Patel, Tejash T., Keith, Scott W., Eldredge-Hindy, Harriet, Fisher, Scot A., Palmer, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503853/
https://www.ncbi.nlm.nih.gov/pubmed/34660939
http://dx.doi.org/10.1016/j.adro.2021.100782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503853/
https://www.ncbi.nlm.nih.gov/pubmed/34660939
http://dx.doi.org/10.1016/j.adro.2021.100782

Ejemplares similares